Advertisement
Advertisement

AVDL

AVDL logo

Avadel Pharmaceuticals plc

10.72
USD
-0.21
-1.92%
Dec 17, 15:59 UTC -5
Closed
...

Avadel Pharmaceuticals plc Profile

About

Avadel Pharmaceuticals plc is a specialty pharmaceutical company. Its product pipeline consists of hospital and paediatrics. Hospital segment provides Bloxiverz(R), Vazculep(R) and Akovaz(TM). Paediatrics segment provides Karbinal (TM) ER, AcipHex(R) Sprinkle and Flexichamber(TM). The company operates primarily in Ireland, USA and France. Avadel Pharmaceuticals plc, formerly known as Flamel Technologies SA, is headquartered in Lyon, France.

Info & Links

CEO

Gregory J. Divis

Headquarters

10 EARLSFORT TERRACE
DUBLIN, L2 D02 T380, IRELAND

Industry

Pharmaceuticals Major

Sector

Health Technology

Website

www.avadel.com

Auditor

Deloitte and Touche LLP

Share holders

58

Employees

154

Avadel Pharmaceuticals plc Statistics

Valuation Measures

Market Capitalization2

1.03B

Enterprise Value

1.00B

Enterprise Value/EBITDA(ttm)

-16.20

Price to Earnings Ratio(ttm)

--

Price to Sales(ttm)

7.25

Price to Book(mrq)

13.41

Price to Cash(ytd)

--

Profitability

Gross Margin(ttm)

92.95%

Operating Margin(ttm)

-52.53%

Profit Margin(ttm)

-71.78%

Return on Equity(ttm)

-93.34%

Return on Invested Capital(ttm)

-90.87%

Return on Assets(ttm)

-44.77%

Income Statement

Revenue(ttm)

138.16M

Revenue Per Share(ttm)

--

Gross Profit(ttm)

127.00M

EBITDA(ttm)3

-62.01M

Net Income Available to Common(ttm)

-72.58M

Diluted EPS(ttm)

-0.79

Share Statistics

Beta (5Y Monthly)

1.32

52-Week Change

-18.23%

S&P 500 52-Week Change

27.63%

S&P 500 Member

Yes

Stock Optionable

Yes

Total Shares Outstanding1

--

Dividend Yield

0.00%

Float4

91.74M

% Held by Insiders

4.80%

% Held by Institutions

69.19%

Balance Sheet

Total Cash(mrq)

65.81M

Total Cash Per Share(mrq)

--

Total Debt(mrq)

0.00

Total Debt/Equity(mrq)

0.00%

Current Ratio(mrq)

2.97%

Quick Ratio(mrq)

2.60%

Book Value Per Share(mrq)

0.78

Cash Flow

Operating Cash Flow Per Share(ytd)

-0.57

Free Cash Flow(ytd)

-54.78M

Table Key

mrq = Most Recent Quarter

ttm = Trailing Twelve Months

ytd = Year To Date

Footnotes

Data provided by Zacks Investment Research or calculated by FXEmpire. All numbers are rounded to the closest decimal.

  • 1 Total Shares outstanding is taken from the most recently filed quarterly or annual report.
  • 2 Market Cap is calculated using total shares outstanding and the most recent share price.
  • 3 EBITDA is calculated using methodology that may differ from that used by a company in its reporting.
  • 4 The float is a measure of the number of shares available for trading by the public. It's calculated by taking the number of issued and outstanding shares minus any restricted stock, which might not be publicly traded.
Advertisement